Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Intervalo de año de publicación
1.
Clin. transl. oncol. (Print) ; 24(12): 2366-2378, dec. 2022.
Artículo en Inglés | IBECS | ID: ibc-216083

RESUMEN

Purpose Papillary thyroid carcinoma (PTC) is the most frequent subtype of thyroid cancer; Hashimoto's thyroiditis (HT), autoimmune disease, commonly affects the thyroid gland; there is possibly a correlation between both, but the exact mechanisms that involve this relationship are still under debate. Since oxidative stress (OS) and the inflammatory environment participate in the development of several types of cancer, the objective of the present study was to establish the microenvironment and systemic participation of OS and inflammatory markers in patients with PTC and HT. Methods Blood and tissue samples were collected from 115 patients: BENIGN (n = 63); PTC (n = 27); HT (n = 15) and PTC + HT (n = 10), and sixty-three were samples from healthy individuals (control group). Results Superoxide dismutase, Catalase, reduced Glutathione, markers of lipid peroxidation and inflammation were evaluated in blood. Immunohistochemistry was performed on 3-nitrotyrosine, 4-hydroxynonenal, Ki-67 and VEGF. The results indicate that antioxidant enzymes were more active in groups with thyroid disorders compared to control, while the concentration of Reduced glutathione was reduced in BENIGN and PTC groups. When PTC and PTC + HT groups were analyzed, no significant differences were found in relation to the antioxidant defense and inflammatory markers. The ability to contain the induced lipid peroxidation was lower and a high level of malondialdehyde was observed in the PTC group. All immunohistochemical markers had higher scores in the PTC group compared to PTC + HT. Conclusion There was a more pronounced presence of OS and a greater activity of cell proliferation and angiogenesis markers in PTC than in PTC + HT group (AU)


Asunto(s)
Humanos , Carcinoma Papilar/patología , Enfermedad de Hashimoto/complicaciones , Cáncer Papilar Tiroideo/patología , Antioxidantes , Catalasa , Glutatión , Antígeno Ki-67 , Malondialdehído , Estrés Oxidativo , Superóxido Dismutasa , Microambiente Tumoral , Factor A de Crecimiento Endotelial Vascular/metabolismo
2.
Clin Transl Oncol ; 24(12): 2366-2378, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-35902455

RESUMEN

PURPOSE: Papillary thyroid carcinoma (PTC) is the most frequent subtype of thyroid cancer; Hashimoto's thyroiditis (HT), autoimmune disease, commonly affects the thyroid gland; there is possibly a correlation between both, but the exact mechanisms that involve this relationship are still under debate. Since oxidative stress (OS) and the inflammatory environment participate in the development of several types of cancer, the objective of the present study was to establish the microenvironment and systemic participation of OS and inflammatory markers in patients with PTC and HT. METHODS: Blood and tissue samples were collected from 115 patients: BENIGN (n = 63); PTC (n = 27); HT (n = 15) and PTC + HT (n = 10), and sixty-three were samples from healthy individuals (control group). RESULTS: Superoxide dismutase, Catalase, reduced Glutathione, markers of lipid peroxidation and inflammation were evaluated in blood. Immunohistochemistry was performed on 3-nitrotyrosine, 4-hydroxynonenal, Ki-67 and VEGF. The results indicate that antioxidant enzymes were more active in groups with thyroid disorders compared to control, while the concentration of Reduced glutathione was reduced in BENIGN and PTC groups. When PTC and PTC + HT groups were analyzed, no significant differences were found in relation to the antioxidant defense and inflammatory markers. The ability to contain the induced lipid peroxidation was lower and a high level of malondialdehyde was observed in the PTC group. All immunohistochemical markers had higher scores in the PTC group compared to PTC + HT. CONCLUSION: There was a more pronounced presence of OS and a greater activity of cell proliferation and angiogenesis markers in PTC than in PTC + HT group.


Asunto(s)
Carcinoma Papilar , Enfermedad de Hashimoto , Neoplasias de la Tiroides , Antioxidantes , Carcinoma Papilar/patología , Catalasa , Glutatión , Enfermedad de Hashimoto/complicaciones , Humanos , Antígeno Ki-67 , Malondialdehído , Estrés Oxidativo , Superóxido Dismutasa , Cáncer Papilar Tiroideo , Neoplasias de la Tiroides/patología , Microambiente Tumoral , Factor A de Crecimiento Endotelial Vascular/metabolismo
4.
Pathol Res Pract ; 216(9): 153098, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-32825964

RESUMEN

Thyroid cancer (TC) is the most prevalent malignant neoplasm that affects the endocrine system. Hashimoto's thyroiditis (HT), also known as chronic lymphocytic thyroiditis, is the most common autoimmune thyroid disease (AITD) that, together with Graves' disease (GD), represent the main autoimmune diseases that affect the thyroid gland. Some studies suggest a greater risk of AITD and the development of TC, while others, investigate its relationship with TC progression and patient prognosis. In this review, we have analyzed published data on the molecular aspects related to the association between AITD and TC, addressing their influence on TC progression, diagnosis, and prognosis of the patients. MEDLINE database (PubMed) platform was used as a search engine and the original articles related to the topic were selected using the keywords combination "thyroid cancer and Hashimoto thyroiditis" or "thyroid carcinoma and thyroid autoimmune disease". After the selection, we categorized the main findings of the papers into four topics: antitumor immunity, tumor progression, diagnosis, and prognosis. Although most of the studies have pointed out the presence of AITD as a factor that increases the risk of TC, few molecular mechanisms to support this conclusion have been described. Additionally, little information is available to explain, pathophysiologically, the effects of autoimmunity in TC diagnosis, progression, and prognosis.


Asunto(s)
Enfermedades Autoinmunes/genética , Enfermedad de Graves/inmunología , Enfermedad de Hashimoto/inmunología , Neoplasias de la Tiroides/patología , Enfermedades Autoinmunes/inmunología , Enfermedades Autoinmunes/patología , Predisposición Genética a la Enfermedad/genética , Enfermedad de Graves/patología , Enfermedad de Hashimoto/patología , Humanos , Glándula Tiroides/inmunología , Glándula Tiroides/patología , Neoplasias de la Tiroides/inmunología
5.
Muscle Nerve ; 56(5): 975-981, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28029692

RESUMEN

INTRODUCTION: We sought to verify whether isoflavin-beta (Iso-ß), a mixture of isoflavones with antioxidant properties, could prevent thyrotoxicosis-induced loss of muscle mass and the participation of oxidative stress (OS) in the mechanisms of this prevention. METHODS: Two experimental periods of thyrotoxicosis induction were used in Wistar rats: 3 and 5 days to assess Iso-ß effects before and after thyrotoxicosis-induced muscle wasting. After euthanasia, peritoneal fat and gastrocnemius muscle were collected, weighed, and muscle OS was assessed. RESULTS: Iso-ß prevented the loss of gastrocnemius mass in thyrotoxic rats through the prevention of muscle OS generation during thyrotoxicosis, increasing muscle total antioxidant capacity and decreasing mitochondrial cytochrome c oxidase activity, lipid peroxidation, and protein carbonyl content. CONCLUSION: Iso-ß decreased oxidative modification of proteins, which is known to exert a major role during proteolysis induction and is present in thyrotoxic myopathy, highlighting the potential action of Iso-ß in this complication of the disease. Muscle Nerve 56: 975-981, 2017.


Asunto(s)
Antioxidantes/uso terapéutico , Isoflavonas/uso terapéutico , Estrés Oxidativo/efectos de los fármacos , Tirotoxicosis/patología , Tirotoxicosis/prevención & control , Animales , Antioxidantes/farmacología , Quimotripsina/metabolismo , Ciclohexanoles/sangre , Ciclohexanoles/toxicidad , Modelos Animales de Enfermedad , Esquema de Medicación , Complejo IV de Transporte de Electrones/metabolismo , Glicerol/sangre , Isoflavonas/farmacología , Masculino , Músculo Esquelético/efectos de los fármacos , Músculo Esquelético/patología , Atrofia Muscular , Carbonilación Proteica/efectos de los fármacos , Ratas , Ratas Wistar , Superóxido Dismutasa/metabolismo , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Tirotoxicosis/sangre , Tirotoxicosis/inducido químicamente , terc-Butilhidroperóxido/metabolismo
6.
J. health inform ; 7(1): 23-29, jan.-mar. 2015. ilus
Artículo en Portugués | LILACS | ID: lil-749233

RESUMEN

Desenvolver um modelo para o banco de dados de vozes brasileiro para armazenar dados do paciente e amostras de áudio capturados, mantendo um histórico de avaliação e tratamento, e possibilitar o diagnóstico automatizado de doenças mentais. Métodos: Pesquisar sobre testes relacionados ao diagnóstico tradicional e pela voz das doenças mentais com a finalidade de promover a abstração de entidades e atributos necessários na constituição da base de dados. Criação do Modelo Entidade-Relacionamento, mapeamento para o Modelo Relacional e criação do Diagrama de Classes. Resultados: Criação do modelo para o Banco de Dados de Vozes Brasileiro. Conclusão: A modelagem foi desenvolvida, de forma que a base de dados possa ser construída e utilizada...


Develop a model for the database of Brazilian voices to store data of patients and captured voices samples. This model supports the automated diagnosis of mental disorders. Method: Research about tests related to tradicional diagnosis and based on voice of mental deseases in order to find the entities and attributes required for database. Creation of the entity-relationship model, mapping to a relational model and the class diagram. Results: Creation the model for the database of Brazilian voices. Conclusion: The modeling was developed and the database can be built and performed...


Desarrollar un modelo para la base de datos de voces brasileñas para almacenar los datos del paciente y muestras de audio captadas por mantener una historia de la evaluación y el tratamiento, y poder hacer un diagnóstico automatizado de la enfermedad mental. Métodos: Se realizó una búsqueda en los diagnósticos tradicionales conexos y la voz de lo trastorno mental con el fin de promover la captación de entidades y atributos requeridos en la constitución de las pruebas de base de datos. Creación del modelo Entidad-Relación, Modelo Relacional para el mapeo y la creación del diagrama de clases. Resultados: La creación del modelo de base de datos para las voces brasileñas. Conclusión: El modelo fue desarrollado para que la base de datos se puede construir y usada...


Asunto(s)
Humanos , Bases de Datos como Asunto , Trastornos Mentales/diagnóstico , Voz
7.
Cell Tissue Res ; 357(3): 803-14, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24842047

RESUMEN

The role of reactive oxygen species (ROS) in muscle protein hydrolysis and protein oxidation in thyrotoxicosis has not been explored. This study indicates that ROS play a role in skeletal muscle wasting pathways in thyrotoxicosis. Two experimental groups (rats) were treated for 5 days with either 3,3',5-triiodothyronine (HT) or HT with α-tocopherol (HT + αT). Two controls were used, vehicle (Control) and control treated with αT (Control + αT). Serum T3, peritoneal fat, serum glycerol, muscle and body weight, temperature, mitochondrial metabolism (cytochrome c oxidase activity), oxidative stress parameters and proteolytic activities were examined. High body temperature induced by HT returned to normal when animals were treated with αT, although total body and muscle weight did not. An increase in lipolysis was observed in the HT + αT group, as peritoneal fat decreased significantly together with an increase in serum glycerol. GSH, GSSG and total radical-trapping antioxidant parameter (TRAP) decreased and catalase activity increased in the HT group. The glutathione redox ratio was higher in HT + αT than in both HT and Control + αT groups. Carbonyl proteins, AOPP, mitochondrial and chymotrypsin-like proteolytic activities were higher in the HT group than in the Control. HT treatment with αT restored mitochondrial metabolism, TRAP, carbonyl protein, chymotrypsin-like activity and AOPP to the level as that of the Control + αT. Calpain activity was lower in the HT + αT group than in HT and Control + αT and superoxide dismutase (SOD) activity was higher in the HT + αT group than in the Control + αT. Although αT did not reverse muscle loss, ROS was involved in proteolysis to some degree.


Asunto(s)
Músculos/patología , Especies Reactivas de Oxígeno/metabolismo , Tirotoxicosis/patología , Síndrome Debilitante/patología , Animales , Antioxidantes/metabolismo , Peso Corporal/efectos de los fármacos , Calpaína/metabolismo , Citocromos c/metabolismo , Masculino , Malondialdehído/metabolismo , Músculos/efectos de los fármacos , Tamaño de los Órganos/efectos de los fármacos , Ratas Wistar , Tirotoxicosis/complicaciones , Triyodotironina/sangre , Triyodotironina/farmacología , Síndrome Debilitante/complicaciones , alfa-Tocoferol/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA